At Applied Materials, we work closely with our pharma partners to use advanced manufactuing technologies to help deliver higher yields and faster time to market as Pharma 4.0 technology is increasingly widely adopted.
We identify the critical metrics to prioritize against including enhanced(e) Quality(Q), Yield(Y), Productivity(P), and accelerated time to market(t). To drive improvement through emerging pharma 4.0 manufacturing, we’ve adopted this eQYPt set of criteria to measure and optimize productivity.
Quality is the number one priority in pharma manufacturing due to the high saftey risk associated with the industry and the heavily regulated environment it operates in. Yield of manufacturing processes (batch or continuous) is prudent for improving operational margins and to respond to demand, while productivity improves supply chain resilency, time to market, and better return on capital employed (ROCE). To optimize a patient-centric focused outcome for pharma manufacturers, all three of these performance indicators must work in concert to accelerate time to market (t).
By addressing the critical questions that pharma leaders are asking in each area of the eQYPt approach, we can build a digital strategy around the most essential KPIs in the industry (see Table 1)
Table 1. Questions that Pharma Leaders Are Asking
|
|
Quality-related Questions
|
|
|
Yield-related Questions
|
 |
Productivity-related Questions
|
 |
Time-related Questions
|
In conclusion, success in today’s pharmaceutical climate depends on asking the right questions and building strategies around the most essential KPIs. These include enhancing Quality, Yield, and Productivity to accelerate time-to-market (eQYPt).
Ready to learn more about how SmartFactory Rx® solutions can help address these questions?
